One-Year Results of Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Authors:
- Ayana YamashitaAYAyana Yamashita
- Fumio ShiragaFSFumio Shiraga
- Chieko ShiragamiCSChieko Shiragami
- Aoi OnoAOAoi Ono
- Kaori TenkumoKTKaori Tenkumo
- 1 March 2010
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 149 (3) , 465-471.e1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Guidelines for PDT in JapanOphthalmology, 2008
- Verteporfin Therapy of Subfoveal Minimally Classic Choroidal Neovascularization in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2005
- Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degenerationAmerican Journal of Ophthalmology, 2003
- Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium–Derived FactorInvestigative Ophthalmology & Visual Science, 2003
- Polypoidal Choroidal VasculopathyArchives of Ophthalmology (1950), 2003
- Verteporfin Therapy of Subfoveal Choroidal Neovascularization in Patients With Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2002
- Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2002
- Polypoidal choroidal vasculopathy: natural historyAmerican Journal of Ophthalmology, 2002
- Polypoidal Choroidal Vasculopathy and Neovascularized Age-related Macular DegenerationArchives of Ophthalmology (1950), 1999
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999